1. Leukocyte telomere length and renal cell carcinoma survival in two studies.
- Author
-
Callahan CL, Schwartz K, Ruterbusch JJ, Shuch B, Graubard BI, Lan Q, Cawthon R, Baccarelli AA, Chow WH, Rothman N, Hofmann JN, and Purdue MP
- Subjects
- Aged, Biomarkers, Tumor blood, Biomarkers, Tumor genetics, Carcinoma, Renal Cell blood, Carcinoma, Renal Cell genetics, Carcinoma, Renal Cell mortality, Case-Control Studies, Colorectal Neoplasms blood, Colorectal Neoplasms genetics, Colorectal Neoplasms mortality, Female, Humans, Kidney Neoplasms blood, Kidney Neoplasms genetics, Kidney Neoplasms mortality, Lung Neoplasms blood, Lung Neoplasms genetics, Lung Neoplasms mortality, Male, Middle Aged, Ovarian Neoplasms blood, Ovarian Neoplasms genetics, Ovarian Neoplasms mortality, Prognosis, Prostatic Neoplasms blood, Prostatic Neoplasms genetics, Prostatic Neoplasms mortality, Survival Rate, Carcinoma, Renal Cell ultrastructure, Colorectal Neoplasms ultrastructure, Kidney Neoplasms ultrastructure, Leukocytes ultrastructure, Lung Neoplasms ultrastructure, Ovarian Neoplasms ultrastructure, Prostatic Neoplasms ultrastructure, Telomere ultrastructure, Telomere Shortening
- Abstract
Background: Leukocyte telomere length (LTL) is a potential biomarker of cancer prognosis; however, evidence for renal cell carcinoma (RCC) is inconsistent., Methods: We investigated LTL and RCC-specific survival among 684 cases from the US kidney cancer study (USKC) and 241 cases from the prostate, lung, colorectal, and ovarian cancer screening trial (PLCO). Leukocyte telomere length was measured by quantitative polymerase chain reaction, and hazard ratios (HRs) and 95% confidence intervals (CIs) computed using multivariable Cox models., Results: Short LTL was associated with poorer disease-specific survival in both USKC (lowest vs highest quartile: HR: 2.3, 95% CI: 1.2-4.4; P for trend=0.02) and PLCO (HR: 2.4, 95% CI: 1.0-5.4; P=0.04). Among USKC cases, the association was strongest for stage-I RCC (HR: 5.5, 95% CI: 1.6-19.0; P=0.006)., Conclusions: Our findings suggest that shorter LTL is an independent marker of poor RCC prognosis, particularly for stage-I disease.
- Published
- 2017
- Full Text
- View/download PDF